AR070339A1 - Metodos para mejorar la deposicion de dha y las funciones y/o el desarrollo relacionados con ella - Google Patents

Metodos para mejorar la deposicion de dha y las funciones y/o el desarrollo relacionados con ella

Info

Publication number
AR070339A1
AR070339A1 ARP090100318A ARP090100318A AR070339A1 AR 070339 A1 AR070339 A1 AR 070339A1 AR P090100318 A ARP090100318 A AR P090100318A AR P090100318 A ARP090100318 A AR P090100318A AR 070339 A1 AR070339 A1 AR 070339A1
Authority
AR
Argentina
Prior art keywords
animals
humans
dha
lipids
sda
Prior art date
Application number
ARP090100318A
Other languages
English (en)
Inventor
Gary F Hartnell
Shawna L Lemke
Original Assignee
Monsanto Technology Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Monsanto Technology Llc filed Critical Monsanto Technology Llc
Publication of AR070339A1 publication Critical patent/AR070339A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Medicinal Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fodder In General (AREA)

Abstract

Método para la deposicion mejorada de DHA (ácido decosahexnoico) en tejidos de seres humanos o animales mediante la incorporacion de lípidos saludables que contienen ácido estearidonico (SDA) en seres humanos o animales, por medio de la administracion prolongada de alimentos para seres humanos o animales, así como suplementos, y agentes terapéuticos. La deposicion mejorada de DHA mediante el consumo de composiciones comestibles que comprenden ácido estearidonico puede usarse para mejorar numerosos indicadores de la salud y el desarrollo, incluyendo indicadores de la salud del corazon, la funcion y el desarrollo neurologicos, y el índice omega-3 en los tejidos. Reivindicacion 101: Una composicion comestible para el consumo por parte de animales que comprende SDA caracterizada porque dicha composicion comestible se prepara con un método que comprende: a) proveerle un alimento que comprende SDA a un animal, b) extraer un tejido o un fluido que comprende lípidos de dicho animal, c) extraer al menos una porcion de dichos lípidos de dicho tejido o fluido, y d) incorporar al menos una porcion de dichos lípidos en un alimento para seres humanos o animales, un suplemento, o un agente terapéutico que ha de ser consumido por seres humanos o animales.
ARP090100318A 2008-01-31 2009-01-30 Metodos para mejorar la deposicion de dha y las funciones y/o el desarrollo relacionados con ella AR070339A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6327508P 2008-01-31 2008-01-31

Publications (1)

Publication Number Publication Date
AR070339A1 true AR070339A1 (es) 2010-03-31

Family

ID=40551998

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP090100318A AR070339A1 (es) 2008-01-31 2009-01-30 Metodos para mejorar la deposicion de dha y las funciones y/o el desarrollo relacionados con ella

Country Status (3)

Country Link
US (1) US20090197955A1 (es)
AR (1) AR070339A1 (es)
WO (1) WO2009099886A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150157048A1 (en) * 2013-12-11 2015-06-11 Mead Johnson Nutrition Company Nutritional compositions containing stearidonic acid and uses thereof
CN104792530B (zh) * 2015-04-15 2017-03-22 北京航空航天大学 一种基于SDA和Softmax回归的深度学习滚动轴承故障诊断方法
CN104914207B (zh) * 2015-06-29 2017-03-15 通威股份有限公司 一种裂殖壶菌藻粉中dha含量的测定方法

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1263270A (en) * 1987-08-19 1989-11-28 Bruce J. Holub Animal feed supplement
GB9012651D0 (en) * 1990-06-06 1990-07-25 Efamol Holdings Essential fatty acid treatment
FR2679109B1 (fr) * 1991-07-18 1994-03-11 Institut Recherche Biologique Sa Nouveaux complements nutritionnels ou dietetiques anti-vieillissement a base d'acide gras poly-insature.
US5308832A (en) * 1992-07-27 1994-05-03 Abbott Laboratories Nutritional product for persons having a neurological injury
AU683027B2 (en) * 1993-01-27 1997-10-30 Scotia Holdings Plc Triglycerides
US5716614A (en) * 1994-08-05 1998-02-10 Molecular/Structural Biotechnologies, Inc. Method for delivering active agents to mammalian brains in a complex with eicosapentaenoic acid or docosahexaenoic acid-conjugated polycationic carrier
ES2179156T3 (es) * 1996-11-20 2003-01-16 Nutricia Nv Composicion nutricional que incluye grasas para el tratamiento del sindrome metabolico.
AU7222598A (en) * 1997-04-29 1998-11-24 Scotia Holdings Plc Treatment of depression and anxiety using docosahexaenoic acid or natural antioxidants
US7112609B2 (en) * 1999-06-01 2006-09-26 Drugtech Corporation Nutritional supplements
US6998501B1 (en) * 1999-08-30 2006-02-14 Ocean Nutrition Canada Limited Nutritional supplement for lowering serum triglyceride and cholesterol levels
US6340705B1 (en) * 1999-09-10 2002-01-22 Monsanto Technology, Llc Use of α-linolenic acid metabolites for treatment or prevention of cancer
US6596302B2 (en) * 2000-04-13 2003-07-22 Abbott Laboratories Infant formulas containing long-chain polyunsaturated fatty acids and uses thereof
ATE301401T1 (de) * 2000-05-18 2005-08-15 Mega Healthcare As Q Nahrungsergänzungsmittel mit vitaminen, mineralien und mehrfach ungesättigten fettsäuren
US6667064B2 (en) * 2000-08-30 2003-12-23 Pilot Therapeutics, Inc. Composition and method for treatment of hypertriglyceridemia
US20040037892A1 (en) * 2001-11-19 2004-02-26 Adrianne Bendich Dietary composition containing conjugated linoleic acid and calcium for improved health
US6576253B2 (en) * 2000-12-05 2003-06-10 Pbm Pharmaceuticals, Inc. Food bars containing nutritional supplements
US6569445B2 (en) * 2000-12-05 2003-05-27 Pbm Pharmaceuticals, Inc. Food bars containing nutritional supplements and anti-constipation and regularity maintaining-agents
US7001610B2 (en) * 2001-04-23 2006-02-21 Omeganutrel Inc. Food supplement and use thereof for elevating levels of essential fatty acids in livestock and products therefrom
GB0111282D0 (en) * 2001-05-09 2001-06-27 Laxdale Ltd Potentiation of therapeutic effects of fatty acids
EP2275101A1 (en) * 2001-05-14 2011-01-19 Martek Biosciences Corporation Polar lipid-rich fraction containing stearidonic acid and gamma linolenic acid from plant seeds and microbes, and its uses
WO2002092779A2 (en) * 2001-05-17 2002-11-21 Pilot Therapeutics, Inc. Method for enriching tissues in long chain polyunsaturated fatty acids
WO2002096408A1 (en) * 2001-05-30 2002-12-05 Laxdale Limited Coenzyme q and eicosapentaenoic acid (epa)
US20040009160A1 (en) * 2001-06-22 2004-01-15 Villamar Daniel F Bioactive food complex, method for making bioactive food complex product and method for controlling disease
WO2003017945A2 (en) * 2001-08-24 2003-03-06 Martek Biosciences Boulder Corporation Products containing highly unsaturated fatty acids for use by women and their children during stages of preconception, pregnancy and lactation/post-partum
US7704542B2 (en) * 2001-09-12 2010-04-27 Xanodyne Pharmaceuticals, Inc. Vitamin/mineral compositions with DHA
US20030077342A1 (en) * 2001-10-09 2003-04-24 Maf Group, Llc Anti-inflammatory complex containing eicosapentaenoic acid
EP1489915A4 (en) * 2002-03-08 2005-09-14 Monsanto Technology Llc TREATMENT AND PREVENTION OF INFLAMMATORY DISORDERS
US20040048926A1 (en) * 2002-03-15 2004-03-11 Hoffman Dennis Robert Use of docosahexaenoic acid and arachidonic acid to enhance the visual development of term infants breast-fed up to the age of six months
US7670612B2 (en) * 2002-04-10 2010-03-02 Innercap Technologies, Inc. Multi-phase, multi-compartment capsular delivery apparatus and methods for using same
US20040001874A1 (en) * 2002-06-24 2004-01-01 Vital Living, Inc. Safe and effective nutritional supplement formulations and associated regimens adapted to prevent and/or treat targeted diseases or medical or health conditions, and related methods
US20040076695A1 (en) * 2002-07-08 2004-04-22 Advanced Vision Research EPA and DHA enriched omega-3 supplement for the treatment of dry eye, meibomianitis and xerostomia
US20060078533A1 (en) * 2004-10-12 2006-04-13 Omoigui Osemwota S Method of prevention and treatment of aging and age-related disorders including atherosclerosis, peripheral vascular disease, coronary artery disease, osteoporosis, arthritis, type 2 diabetes, dementia, alzheimer's disease and cancer
DE10324548A1 (de) * 2003-05-28 2004-12-16 Nutrinova Nutrition Specialties & Food Ingredients Gmbh Diätisches Lebensmittel bei einer gewichtskontrollierenden bzw. gewichtsreduzierenden Ernährung
US8921422B2 (en) * 2003-10-01 2014-12-30 The Iams Company Methods and kits for enhancing ability to learn in a puppy or kitten
US20050130937A1 (en) * 2003-10-22 2005-06-16 Enzymotec Ltd. Lipids containing omega-3 and omega-6 fatty acids
SE0303513D0 (sv) * 2003-12-19 2003-12-19 Pronova Biocare As Use of a fatty acid composition comprising at least one of epa and dha or any combinations thereof
BRPI0509944A (pt) * 2004-04-16 2007-09-25 Monsanto Technology Llc expressão de dessaturases de ácido graxo em milho
US20050244367A1 (en) * 2004-05-03 2005-11-03 Ilypsa, Inc. Phospholipase inhibitors localized in the gastrointestinal lumen
US20050266051A1 (en) * 2004-05-27 2005-12-01 The Procter & Gamble Company Pet food compositions and methods
US7476799B2 (en) * 2004-07-07 2009-01-13 Jeffrey Howard Purchon Sound-effect foot pedal for electric/electronic musical instruments
US20080020102A1 (en) * 2004-07-13 2008-01-24 Rutgers, The State University Of New Jersey Omega Fatty Acid Fortified Food Products And Methods For Preparing Same
US20060088574A1 (en) * 2004-10-25 2006-04-27 Manning Paul B Nutritional supplements
ATE469957T1 (de) * 2004-11-04 2010-06-15 Monsanto Technology Llc Verfahren zur herstellung von ölzusammensetzungen
WO2006063219A2 (en) * 2004-12-09 2006-06-15 Pro-Health, Inc. Product and method for oral administration of nutraceuticals
US8324276B2 (en) * 2005-01-24 2012-12-04 Pronova Biopharma Norge As Fatty acid composition for treatment of alzheimer's disease and cognitive dysfunction
US20060246115A1 (en) * 2005-03-04 2006-11-02 Ricardo Rueda Nutritional products for ameliorating symptoms of rheumatoid arthritis
US20060228403A1 (en) * 2005-04-12 2006-10-12 Zimmerman Karl A Nutritional supplements for cardiovascular health
DE102005052551A1 (de) * 2005-11-02 2007-05-16 Rothamsted Res Harpenden Verfahren zur Herstellung von y-Linolensäure und/oder Stearidonsäure in transgenen Brassicaceae und Linaceae

Also Published As

Publication number Publication date
US20090197955A1 (en) 2009-08-06
WO2009099886A1 (en) 2009-08-13

Similar Documents

Publication Publication Date Title
GB2459809A (en) Fatty acid formulations and methods of use thereof
ES2571856T3 (es) Uso de composiciones nutricionales para prevenir la adiposidad visceral
CO6351747A2 (es) Composicion nutricional para promover desarrollo y crecimiento saludables
ES2659353T3 (es) Métodos y formulaciones nutricionales para aumentar la eficacia y reducir los efectos secundarios del tratamiento del cáncer
MX2019010738A (es) Composiciones que contienen lipidos y metodos para utilizar las mismas.
IN2012DN00760A (es)
BR112012001912A8 (pt) Composições nutritivas que compreendem fibra e probióticos
BRPI0819690B8 (pt) uso de uma composição compreendendo cisteamina ou cistamina, ou um sal farmaceuticamente aceitável das mesmas
PH12017550006A1 (en) Optimized nutrient fatty acid composition
WO2012087742A3 (en) Methods and compositions suitable for managing blood glucose in animals
MX2009001156A (es) Composiciones de vitamina d y metodo de administracion a un ser humano.
MX2010005948A (es) Productos carnicos con niveles incrementados de acidos grasos beneficiosos.
JP2014505702A5 (es)
RU2013146517A (ru) Композиции и способы, пригодные для облегчения возрастных заболеваний
AR097149A1 (es) Método para suministrar una composición alimenticia a rumiantes
JP2015533509A5 (es)
AR070339A1 (es) Metodos para mejorar la deposicion de dha y las funciones y/o el desarrollo relacionados con ella
CN101283797A (zh) 以核桃油为基质的促智健脑保健品
TWI440458B (zh) Containing sesamin and arachidonic acid
PH12016501111A1 (en) Composition comprising ferric saccharate and high concentrations of microencapsulated lc-pufa with a reduced off taste
AR086437A1 (es) Preparado de huevo con propiedades regeneradoras, analgesicas y/o anti-inflamatorias
RO131191A0 (ro) Săpun pentru dinţi realizat din ingrediente naturale
Vicente et al. Perinatal consumption of flaxseed oil and flaxseed flour has beneficial effects on cardiac fibrosis of male offspring from rat dams with experimental diabetes
Abenavoli Role of silymarin to treat fibrosis development in non-alcoholic fatty liver diseasehepr_823 668
KR20150100227A (ko) 여드름 피부 상태 개선용 건강기능식품의 조성물

Legal Events

Date Code Title Description
FB Suspension of granting procedure